Co-operative effect of c-Src and ezrin in deregulation of cell-cell contacts and scattering of mammary carcinoma cells

被引:41
作者
Elliott, BE [1 ]
Qiao, H
Louvard, D
Arpin, M
机构
[1] Queens Univ, Inst Canc Res, Div Canc Biol & Genet, Kingston, ON K7L 3N6, Canada
[2] Queens Univ, Kingston, ON K7L 3N6, Canada
[3] Inst Curie, UMR 144 CNRS, F-75248 Paris, France
关键词
ezrin; c-Src; cadherins; cell-cell contacts; cell scattering; carcinomas;
D O I
10.1002/jcb.20033
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 [生物化学与分子生物学]; 081704 [应用化学];
摘要
The non-receptor tyrosine kinase c-Src is activated in many human cancer types, and induces deregulation of cadherin-based cell-cell contacts and actin cytoskeleton. Because ezrin, a protein which cross-links the plasma membrane with the actin cytoskeleton, is often over-expressed in human cancers, and participates in cell adhesion, motility, and cell scattering, we therefore investigated whether c-Src co-operates with ezrin in regulating cell-cell contacts in a murine mammary carcinoma cell line, SP1. SP1 cells over-expressing wild type ezrin, or an activated c-Src mutant, formed loose aggregates which scattered spontaneously when plated on plastic. When wild type ezrin and activated c-Src were co-expressed, scattering was increased, cell-cell contacts disrupted, and cell aggregation prevented. Pre-treatment with the c-Src family kinase inhibitor PP2 partially restored aggregation of cells expressing activated c-Src and wild type ezrin, indicating that c-Src family kinases act co-operatively with ezrin in regulating cell-cell contacts. Furthermore, expression of a truncated NH2-terminal domain of ezrin, which has dominant negative function, blocked the cell scattering effect of activated c-Src and promoted formation of cohesive cell-cell contacts. Together, these results suggest co-operativity between c-Src and ezrin in deregulation of cell-cell contacts and enhancing scattering of mammary carcinoma cells. (C) 2004 Wiley-Liss, Inc.
引用
收藏
页码:16 / 28
页数:13
相关论文
共 41 条
[1]
EZRIN CONTAINS CYTOSKELETON AND MEMBRANE-BINDING DOMAINS ACCOUNTING FOR ITS PROPOSED ROLE AS A MEMBRANE-CYTOSKELETAL LINKER [J].
ALGRAIN, M ;
TURUNEN, O ;
VAHERI, A ;
LOUVARD, D ;
ARPIN, M .
JOURNAL OF CELL BIOLOGY, 1993, 120 (01) :129-139
[2]
Ezrin is a substrate for Lck in T cells [J].
Autero, M ;
Heiska, L ;
Rönnstrand, L ;
Vaheri, A ;
Gahmberg, CG ;
Carpén, O .
FEBS LETTERS, 2003, 535 (1-3) :82-86
[3]
Src-induced de-regulation of E-cadherin in colon cancer cells requires integrin signalling [J].
Avizienyte, E ;
Wyke, AW ;
Jones, RJ ;
McLean, GW ;
Westhoff, MA ;
Brunton, VG ;
Frame, MC .
NATURE CELL BIOLOGY, 2002, 4 (08) :632-638
[4]
Identification of protein-tyrosine phosphatase 1B as the major tyrosine phosphatase activity capable of dephosphorylating and activating c-Src in several human breast cancer cell lines [J].
Bjorge, JD ;
Pang, A ;
Fujita, DJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (52) :41439-41446
[5]
Selected glimpses into the activation and function of Src kinase [J].
Bjorge, JD ;
Jakymiw, A ;
Fujita, DJ .
ONCOGENE, 2000, 19 (49) :5620-5635
[6]
ERM proteins and merlin: Integrators at the cell cortex [J].
Bretscher, A ;
Edwards, K ;
Fehon, RG .
NATURE REVIEWS MOLECULAR CELL BIOLOGY, 2002, 3 (08) :586-599
[7]
ERM-merlin and EBP50 protein families in plasma membrane organization and function [J].
Bretscher, A ;
Chambers, D ;
Nguyen, R ;
Reczek, D .
ANNUAL REVIEW OF CELL AND DEVELOPMENTAL BIOLOGY, 2000, 16 :113-+
[8]
Ezrin is an effector of hepatocyte growth factor-mediated migration and morphogenesis in epithelial cells [J].
Crepaldi, T ;
Gautreau, A ;
Comoglio, PM ;
Louvard, D ;
Arpin, M .
JOURNAL OF CELL BIOLOGY, 1997, 138 (02) :423-434
[9]
Differential function of N-cadherin and cadherin-7 in the control of embryonic cell motility [J].
Dufour, S ;
Beauvais-Jouneau, A ;
Delouvée, A ;
Thiery, JP .
JOURNAL OF CELL BIOLOGY, 1999, 146 (02) :501-516
[10]
The role of hepatocyte growth factor (scatter factor) in epithelial-mesenchymal transition and breast cancer [J].
Elliott, BE ;
Hung, WL ;
Boag, AH ;
Tuck, AB .
CANADIAN JOURNAL OF PHYSIOLOGY AND PHARMACOLOGY, 2002, 80 (02) :91-102